Christopher S. Boerner's Net Worth
$15.1 Million
Who is Christopher S. Boerner?
Christopher S. Boerner has an estimated net worth of $15.1 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, SEATTLE GENETICS INC /WA, and Achaogen Inc.
SEC CIK
Christopher S. Boerner's CIK is 0001543747
Past Insider Trading and Trends
2023 was Christopher S. Boerner's most active year for acquiring shares with 17 total transactions. Christopher S. Boerner's most active month to acquire stocks was the month of February. 2019 was Christopher S. Boerner's most active year for disposing of shares, totalling 16 transactions. Christopher S. Boerner's most active month to dispose stocks was the month of February. 2013 saw Christopher S. Boerner paying a total of $1,564,750.00 for 57,500 shares, this is the most they've acquired in one year. In 2022 Christopher S. Boerner cashed out on 119,778 shares for a total of $4,516,539.07, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.40% | 1.42K |
$54.32 | -$80,828.16 | 102.63K |
Nov 1
| |||
Form 4
| +22.42% | 18.53K |
$53.79 | -$1,043,902.53 | 101.2K |
Mar 10
| |||
Form 4
| +2.48% | 2K |
$49.78 | $99,560.00 | 82.67K |
Dec 5
| |||
Form 4
| +1.62% | 1.29K |
$50.10 | -$67,635.00 | 80.67K |
Dec 2
| |||
Form 4
| +4.02% | 3.07K |
$48.86 | $150,049.06 | 79.38K |
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +76.43% | 33.06K |
$65.71 | -$2,274,880.20 | 76.31K |
Mar 10
| |||
Form 4
| +3.07% | 1.29K |
$81.13 | -$109,444.37 | 43.25K |
Dec 2
| |||
Form 4
| -41.30% | -29.53K |
$69.20 | -$2,043,525.80 | 41.97K |
Mar 14
| |||
Form 4
| +85.65% | 32.99K |
$68.42 | -$2,363,568.90 | 71.5K |
Mar 10
| |||
Form 4
| +3.46% | 1.29K |
$55.41 | -$74,803.50 | 38.51K |
Dec 2
| |||
Form 4
| +66.39% | 14.85K |
$60.93 | -$783,011.43 | 37.22K |
Mar 10
| |||
Form 4
| +6.36% | 1.34K |
$62.18 | -$80,771.82 | 22.37K |
Dec 2
| |||
Form 4
| +124.09% | 11.65K |
$57.68 | -$701,755.81 | 21.03K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
| +226.58% | 6.51K |
$51.39 | -$408,447.72 | 9.39K |
Mar 10
| |||
Form 4
|
∞
| 2.87K |
$49.89 | -$79,374.99 | 2.87K |
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SEATTLE GENETICS INC /WA (SGEN) No price found
Executive Vice President, Comm
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.61% | 14.75K |
$43.55 | -$54,349.15 | 72.36K |
Scheduled
|
Aug 24 - Aug 26
| ||
Form 4
| +21.05% | 10K |
—
|
—
| 57.51K |
Mar 3
| |||
Form 4
| -3.06% | -1.45K |
$54.98 | -$79,825.15 | 46.08K |
Feb 21
| |||
Form 4
| +40.81% | 13.77K |
$40.91 | -$9,245.66 | 47.53K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$24.36 | -$157,312.90 | 33.75K |
Mar 15
| |||
Form 4
| +55.16% | 12K |
—
|
—
| 33.75K |
Aug 20
| |||
Form 4
| +231.92% | 19.32K |
—
|
—
| 27.65K |
Aug 19 - Feb 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Achaogen Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||